PubRank

Gord Blackhouse

Author PubWeight™ 32.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 2002 2.53
2 Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007 2.50
3 Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. J Vasc Surg 2008 1.53
4 Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation. Can J Ophthalmol 2010 1.51
5 Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol 2009 1.51
6 Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin 2007 1.23
7 Effects of study design and trends for EVAR versus OSR. Vasc Health Risk Manag 2008 0.97
8 A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment. Pharmacoeconomics 2010 0.92
9 Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Curr Med Res Opin 2006 0.92
10 Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis. Cost Eff Resour Alloc 2009 0.90
11 Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery. Ont Health Technol Assess Ser 2012 0.89
12 Triple therapy for the management of COPD: a review. COPD 2011 0.87
13 Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol 2009 0.86
14 Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario. Int J Technol Assess Health Care 2009 0.86
15 Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. Can J Gastroenterol 2007 0.86
16 Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Int J Technol Assess Health Care 2008 0.84
17 Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg 2012 0.84
18 Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis. J Stud Alcohol Drugs 2008 0.82
19 Principles of good modeling practice in healthcare cost-effectiveness studies. Expert Rev Pharmacoecon Outcomes Res 2004 0.81
20 Should endovascular repair be reimbursed for low risk abdominal aortic aneurysm patients? Evidence from ontario, Canada. Int J Vasc Med 2011 0.81
21 Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura. Clin Ther 2009 0.80
22 Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Rev Pharmacoecon Outcomes Res 2011 0.79
23 Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies. Expert Rev Pharmacoecon Outcomes Res 2015 0.78
24 Cost-effectiveness of reducing wait times for cataract surgery in Ontario. Can J Ophthalmol 2008 0.78
25 Conditionally funded field evaluations and practical trial design within a health technology assessment framework. J Am Coll Radiol 2009 0.78
26 Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand? Int J Technol Assess Health Care 2008 0.77
27 Health technology assessment and primary data collection for reducing uncertainty in decision making. J Am Coll Radiol 2009 0.77
28 Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients. Circ Cardiovasc Qual Outcomes 2009 0.76
29 Impact of the 1997 Canadian guidelines on the conduct of Canadian-based economic evaluations in the published literature. Value Health 2009 0.76
30 Patient outcomes after anti TNF-alpha drugs for Crohn's disease. Expert Rev Pharmacoecon Outcomes Res 2010 0.76
31 Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol 2012 0.76
32 Approaches for economic evaluations of health care technologies. J Am Coll Radiol 2009 0.75
33 Managing multiple projects: a literature review of setting priorities and a pilot survey of healthcare researchers in an academic setting. Perspect Health Inf Manag 2007 0.75
34 Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Open Med 2010 0.75
35 The excess burden of rheumatoid arthritis in Ontario, Canada. Clin Exp Rheumatol 2012 0.75
36 Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario. Expert Rev Pharmacoecon Outcomes Res 2013 0.75
37 Conditionally funded field evaluations: PATHs coverage with evidence development program for Ontario. Value Health 2010 0.75
38 In search of the evidentiary foundation of published Canadian economic evaluations (2001-06). Int J Technol Assess Health Care 2009 0.75